MG
LFVN icon

Michael Gelband’s LifeVantage LFVN Stock Holding History

Michael Gelband’s Portfolio LFVN Stock Details LFVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,397
Closed -$135K – 2403
2021
Q2 		$135K Buy
+18,397
New +$150K ﹤0.01% 2083
2019
Q2 		– Sell
-32,309
Closed -$462K – 1238
2019
Q1 		$462K Buy
32,309
+20,833
+182% +$302K 0.03% 352
2018
Q4 		$151K Buy
+11,476
New +$137K 0.01% 289

Other funds holding LFVN

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $783M AUM 81.58% 1-Year Est. Return

Michael Gelband's LFVN Position: Q3 2021 in Review

Michael Gelband sold out of LifeVantage (LFVN) in Q3 2021, closing a stake of 18,397 shares — an estimated $135K sold.

Michael Gelband first reported a position in LFVN in Q4 2018 and held it in 3 quarters. The position peaked at $462K in Q1 2019. 60 funds tracked by Wall St. Rank hold LFVN as of Q3 2021.

  • Michael Gelband reported no remaining LifeVantage position as of Q3 2021 after selling out during the quarter.
  • Michael Gelband sold 18,397 LifeVantage shares in Q3 2021, an estimated $135K.
  • Michael Gelband first reported a position in LifeVantage in Q4 2018 and held it in 3 quarters.
  • Michael Gelband's LifeVantage position peaked at $462K in Q1 2019.
  • 60 funds tracked by Wall St. Rank held LifeVantage as of Q3 2021.

Based on ExodusPoint Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.